awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38876395-391AF155-C1FB-40B9-82FE-5BDCE45E9D22
Q38876395-391AF155-C1FB-40B9-82FE-5BDCE45E9D22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38876395-391AF155-C1FB-40B9-82FE-5BDCE45E9D22
Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.
P2860
Q38876395-391AF155-C1FB-40B9-82FE-5BDCE45E9D22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38876395-391AF155-C1FB-40B9-82FE-5BDCE45E9D22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e820810f661c0e0a5e688cf26cf5c38419efada3
P2860
A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder.